APA Alıntı

Kaufman, H. L., Russell, J., Hamid, O., Bhatia, S., Terheyden, P., D’Angelo, S. P., . . . Nghiem, P. (2016). Avelumab in patients with chemotherapy-refractory metastatic Merkel cell carcinoma: A multicentre, single-group, open-label, phase 2 trial. Lancet Oncol.

Chicago Stili Alıntı

Kaufman, Howard L., et al. "Avelumab in Patients With Chemotherapy-refractory Metastatic Merkel Cell Carcinoma: A Multicentre, Single-group, Open-label, Phase 2 Trial." Lancet Oncol 2016.

MLA Alıntı

Kaufman, Howard L., et al. "Avelumab in Patients With Chemotherapy-refractory Metastatic Merkel Cell Carcinoma: A Multicentre, Single-group, Open-label, Phase 2 Trial." Lancet Oncol 2016.